'Unravelling AKT2 Signalling in Cancer through Nanobody Technology' - PhD defence
CRIG member Tijs Merckaert is defending his doctoral thesis entitled 'Unravelling AKT2 Signalling in Cancer through Nanobody Technology'.
- April 21, 16:00
- Via livestream
- Promotors : prof. Kris Gevaert (PhD) & prof. Jan Gettemans (PhD)
- Read more